AI Governance in Healthcare Is No Longer Optional. Here Is What Your Vendor Should Be Able to Prove

The HHS Office for Civil Rights issued over $2.1 billion in HIPAA enforcement fines between 2003 and 2025. AI systems that process PHI without proper safeguards represent one of the fastest-growing categories of compliance risk. Spectrum

That number should be in every AI vendor conversation your organization has in 2026.

Healthcare organizations are deploying AI faster than they are building the governance infrastructure to support it. The tools are live in clinical workflows, in revenue cycle, in ambient documentation systems. The governance frameworks that should surround those tools are months behind.

Only about 20% of organizations report mature frameworks for managing AI agents. In healthcare, where those agents are touching protected health information at every step, that gap is a serious exposure. Healthcare IT Today

Here is what proper governance actually looks like - along with the specific questions your vendors should be able to answer before you sign anything.

What Changed in 2026 That Makes This Urgent Right Now

The regulatory environment around AI in healthcare shifted materially in the last 12 months.

The 2026 HIPAA Security Rule update introduced several requirements that directly impact AI deployments. Mandatory encryption, previously an "addressable" specification, is now required for all ePHI including data processed by AI systems. New vulnerability scanning requirements apply to AI infrastructure. The 72-hour incident notification requirement means organizations need monitoring infrastructure capable of detecting AI-related breaches in near real-time.

Texas's Responsible AI Governance Act, effective January 1, 2026, establishes governance and disclosure requirements for AI systems operating in the state including healthcare. California's AB 489 prohibits AI from implying it holds a healthcare license. Colorado's AI Act adds transparency along with risk management requirements. For multi-state health systems, the compliance matrix now looks nothing like the single-framework HIPAA world they were built for. CapMinds

As of early 2026, the FDA has authorized over 950 AI/ML-enabled medical devices across radiology, cardiology, ophthalmology, gastroenterology, along with other specialties. Every one of those devices exists within a regulatory framework that requires ongoing monitoring, not just initial approval. Elliginthealth

The regulatory landscape is not heading toward more AI governance requirements. It is already there.

The Five Questions Every AI Vendor Should Answer Before You Sign

1. How does your system handle PHI - specifically, is it used for model training?

This is the question that makes vendors squirm most often. Many AI tools improve their models using customer data. In healthcare, that means your patients' protected health information is potentially improving a model that serves other organizations. Your BAA should explicitly address whether PHI can be used for model training. If the vendor cannot give you a direct yes-or-no answer, that is a red flag.

2. What certifications can you provide?

While there is no official government HIPAA certification, look for third-party attestations like a SOC 2 Type II report along with HITRUST CSF certification. These show that a vendor has undergone a rigorous independent audit. A vendor that cannot provide SOC 2 Type II documentation in 2026 is not enterprise-ready for healthcare. ClinDCast

3. How are AI outputs audited after the fact?

AI governance requires access controls, audit trails, along with risk analysis as a standard component of HIPAA compliance review. Ask your vendor how you retrieve an audit trail if an AI output is questioned six months after the fact. If the answer involves manual reconstruction from logs, that is not a real audit capability. Getprosper

4. How does your system handle hallucinations in clinical contexts?

Output quality and hallucinations were cited as the primary data risk by 63% of healthcare IT respondents. A vendor that says their model does not hallucinate is either lying or does not understand their own system. The honest answer involves specific detection mechanisms, validation layers, along with escalation protocols for low-confidence outputs. Elarafy

5. What happens to your data if the vendor is acquired?

The ambient scribe market is consolidating. The AI RCM market is consolidating. The vendor you sign with today may be a different company in 18 months. Your BAA should address data handling, data portability, along with deletion rights in the event of acquisition.

What Local Validation Actually Means

Generic vendor validation proves insufficient for healthcare AI compliance. Organizations must validate AI tools within their specific deployment context, accounting for unique patient populations, clinical workflows, along with operational environments, before clinical implementation. This requirement for local AI validation is non-negotiable along with ongoing, not a one-time checkbox exercise. CapMinds

A radiology AI tool validated on a national dataset of chest X-rays needs to be validated on your specific patient population before it goes into clinical use. Your population may have demographic characteristics, comorbidity profiles, along with imaging equipment differences that affect performance in ways the national dataset did not capture.

This is not the vendor's job to do for you. It is your organization's responsibility. Build it into your AI procurement process as a standard step. Budget for it. Staff for it.

The Shadow AI Problem

Only 10% of healthcare organizations utilize automated product monitoring to detect AI capabilities. The majority rely on informal ad hoc discovery along with vendor release notes, leaving health systems vulnerable to shadow AI. Elarafy

Shadow AI is the AI your organization does not know it is running. Physicians using free AI writing tools to draft notes. Staff using consumer chatbots to process patient scheduling requests. Departments procuring AI tools outside the IT purchasing process.

A common real-world failure is using free public AI tools with PHI, which triggers regulatory exposure along with professional consequences. Getprosper

Build a shadow AI detection process into your governance program. This means regular surveys of staff AI tool usage, IT monitoring for unauthorized API calls, along with a clear escalation path for self-reporting.

For a practical understanding of what this looks like in the context of agentic AI systems specifically, our blog on what hospital CTOs need to know before piloting agentic AI covers the governance infrastructure questions in detail.